Fuller & Thaler Asset Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$414M Buy
857,286
+22,626
+3% +$6M 1.13% 7
2026
Q1
$91.5M Buy
834,660
+11,087
+1% +$1.58M 0.31% 117
2025
Q4
$137M Buy
823,573
+51,651
+7% +$8.64M 0.46% 73
2025
Q3
$151M Buy
771,922
+61,585
+9% +$10.1M 0.51% 60
2025
Q2
$64.2M Buy
710,337
+73,801
+12% +$5.83M 0.23% 160
2025
Q1
$38M Buy
636,536
+128,163
+25% +$11.9M 0.15% 206
2024
Q4
$67.3M Buy
+508,373
New +$47.7M 0.26% 134

Other funds holding ALAB

Fuller & Thaler Asset Management's ALAB Position: Q2 2026 in Review

Fuller & Thaler Asset Management increased its Astera Labs (ALAB) stake by 2.7% in Q2 2026, buying an estimated $6M and bringing the position to 857,286 shares worth $414M. The position accounts for 1.13% of the portfolio, ranked #7.

Fuller & Thaler Asset Management first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Fuller & Thaler Asset Management held 857,286 shares of Astera Labs worth $414M as of Q2 2026.
  • Fuller & Thaler Asset Management bought 22,626 Astera Labs shares in Q2 2026, an estimated $6M.
  • Astera Labs made up 1.13% of Fuller & Thaler Asset Management's portfolio in Q2 2026, its #7 holding.
  • Fuller & Thaler Asset Management first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.